Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors
Anastasios Stathis(Princess Margaret Cancer Centre), C. Sessa(Vita-Salute San Raffaele University), Sara Allegrini(Institute of Oncology Research), Markus Joerger(Kantonsspital St. Gallen), Roger von Moos(Kantonsspital Graubünden), Christoph Ackermann(University of St.Gallen), Dagmar Hess(Kantonsspital St. Gallen), Piera Gargiulo(Swiss Group For Clinical Cancer Research), Simona Berardi(Swiss Group For Clinical Cancer Research), Krisztián Homicskó(University Hospital of Lausanne), Michael Mark(Kantonsspital Graubünden), Gaia Griguolo(University of North Carolina at Chapel Hill), Carlo V. Catapano(Institute of Oncology Research), Alexandros Xyrafas(Swiss Group For Clinical Cancer Research), Milica Enoiu(Swiss Group For Clinical Cancer Research)
Cited by 32
Related Papers
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
|Journal of Clinical Oncology|2011|1.3k
Advanced pancreatic carcinoma: current treatment and future challenges
|Nature Reviews Clinical Oncology|2010|791
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2011|580